As immunotherapy moves beyond traditional PD-1/PD-L1 monotherapy, drug discovery faces new technical bottlenecks. Creative Biolabs addresses these shifts with custom antibody fragment engineering...
As per MarkNtel Advisors the Immune Checkpoint Inhibitor Market size was valued at around USD 51.2 billion in 2023 and is projected to grow at a CAGR of 15.6% during the forecast period of 2025-3...
